Slideshows, Images, and Quizzes
- Rheumatoid Arthritis (RA) Symptoms & TreatmentSource: OnHealth Optimized
What is rheumatoid arthritis (RA)? Learn about juvenile rheumatoid arthritis. Discover rheumatoid arthritis (RA) symptoms, diagnosis, and treatment.
Diseases, Conditions, and Procedures
- Crohn's Disease Source: MedicineNet
Can Crohn's disease kill you? Crohn's disease is an inflammatory bowel disease (IBD) that causes inflammation in the digestive tract. Crohn's disease symptoms include abdominal pain, bloody diarrhea, and weight loss. There are types of Crohn's disease. Several Crohn's disease treatments exist, but there is no cure.
- Ulcerative ColitisSource: MedicineNet
Read about ulcerative colitis causes, and symptoms such as diarrhea, abdominal pain, rectal bleeding, rectal pain, urgency to defecate, or painful bowel movements; diagnosis and treatment options are also discussed.
- Ankylosing SpondylitisSource: MedicineNet
Ankylosing spondylitis causes inflammation of the SI joints and spine. Ankylosing spondylitis causes back pain in addition to problems with the heart, lungs, eyes, and kidneys. Treatments for AS include physical therapy, exercise, and medication.
- SarcoidosisSource: MedicineNet
Read about sarcoidosis, a chronic lung disease. Learn causes, symptoms (cough, erythema nodosum, eye inflammation, fibrosis, granulomas), diagnosis, and treatment.
- What is PsoriasisSource: RxList
Psoriasis is chronic inflammatory skin disease characterized by areas of thickened, inflamed, itchy, red skin, often covered with silvery scales. Psoriasis can affect joints and many areas of the skin, including the scalp.
- FDA Approves Remicade to Treat Ulcerative Colitis in ChildrenSource: FDA
The U.S. Food and Drug Administration today approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.
- FDA Approves Inflectra, a Biosimilar to RemicadeSource: FDA
The U.S. Food and Drug Administration today approved Inflectra (infliximab-dyyb) for multiple indications. Inflectra is administered by intravenous infusion. This is the second biosimilar approved by the FDA.
- FDA Clears Second Remicade BiosimilarSource: RxList
The US Food and Drug Administration (FDA) has approved the infliximab biosimilar product infliximab-abda (Renflexis, Samsung Bioepis) for multiple indications.
- Ulcerative Colitis and RemicadeSource: WebMD Health News
Read about how Remicade can reduce the chance of someone with ulcerative colitis needing their colon removed.
- Combination Therapy Treats Crohn's DiseaseSource: WebMD Health News
For relief from Crohn's disease, a combination of biologic and immunosuppressive therapies appears to be the best initial treatment, according to findings from a clinical trial.
- FDA Advisers Back Infliximab Biosimilar CT-P13Source: WebMD Health News
The US Food and Drug Administration's (FDA's) Arthritis Drugs Advisory Committee gave its backing to CT-P13, a drug that would be the first biosimilar monoclonal antibody approved in the United States.
- Biologic Drug for Early Rheumatoid Arthritis?Source: WebMD Health News
- New Arthritis Drugs Raise Risk of Skin CancerSource: WebMD Health News
Read about the new study showing how new Rheumatoid Arthritis drugs such as Remicade and Enbrel raise the risk of skin cancer on RxList
- Medications for RA Linked to Skin CancerSource: WebMD Health News
RA patients treated with TNF blockers have higher rates of skin cancer than patients who take other disease-modifying antirheumatic drugs, or DMARDs, new studies show.
- Adverse Drug Effects On the RiseSource: WebMD Health News
Read the report of increased adverse drug effects reported to the FDA such as acetaminophen, Tylenol, insulin, Celebrex and more on RxList
- Generic TNF-alpha Inhibitors Comparable to Established BrandsSource: WebMD Health News
Biosimilar tumor necrosis factor-alpha inhibitors appear equivalent to the branded original versions, according to a systematic review and meta-analysis.
- Some IBD Drugs May Raise Skin Cancer RiskSource: WebMD Health News
Patients with inflammatory bowel disease or IBD may be at an increased risk for getting skin cancer, according to a study presented at the American College of Gastroenterology's annual meeting in San Diego.